Table 2.
Baseline patient characteristics of propensity matched patients by completeness of revascularization.*
| Variable | Incomplete Revascularization (n=6,511) |
Complete Revascularization (n=6,511) |
|---|---|---|
| Age (Years) | ||
| <50 | 636(9.8%) | 674(10.4%) |
| 50–59 | 1,524(23.4%) | 1,591(24.4%) |
| 60–69 | 1,838(28.2%) | 1,850(28.4%) |
| 70–79 | 1,712(26.3%) | 1,652(25.4%) |
| ≥ 80 | 801(12.3%) | 744(11.4%) |
| Sex | ||
| Female | 2,191(33.7%) | 2,162(33.2%) |
| Male | 4,320(66.3%) | 4,349(66.8%) |
| Race | ||
| Non-Hispanic white | 5,030(77.3%) | 5,098(78.3%) |
| Non-Hispanic black | 508(7.8%) | 492(7.6%) |
| Hispanic | 546(8.4%) | 514(7.9%) |
| Other | 427(6.6%) | 407(6.3%) |
| Body surface area (m2), mean (SD) | 2.02(0.27) | 2.02(0.26) |
| Body mass index group (kg/m2) | ||
| <18.5 | 56(0.9%) | 60(0.9%) |
| 18.5–24.99 | 1,390(21.3%) | 1,393(21.4%) |
| 25–29.99 | 2,602(40.0%) | 2,560(39.3%) |
| ≥ 30 | 2,463(37.8%) | 2,498(38.4%) |
| Ejection fraction | ||
| <20% | 353(5.4%) | 349(5.4%) |
| 20–29% | 133(2.0%) | 130(2.0%) |
| 30–39% | 313(4.8%) | 308(4.7%) |
| ≥ 40% | 5,707(87.7%) | 5,717(87.8%) |
| Missing | 5(0.1%) | 7(0.1%) |
| Number of diseased vessels | ||
| 2 | 5,782(88.8%) | 5,782(88.8%) |
| 3 | 729(11.2%) | 729(11.2%) |
| Presence of total occlusion | 684(10.5%) | 684(10.5%) |
| Previous myocardial infarction | ||
| 1–7 days | 1,261(19.4%) | 1,247(19.2%) |
| 8–20 days | 122(1.9%) | 109(1.7%) |
| ≥ 21 days | 501(7.7%) | 506(7.8%) |
| No myocardial infarction prior to procedures |
4,627(71.1%) | 4,649(71.4%) |
| Cerebrovascular disease | 460(7.1%) | 461(7.1%) |
| Peripheral arterial disease | 371(5.7%) | 344(5.3%) |
| Hemodynamic state | ||
| Stable | 6,503(99.9%) | 6,501(99.8%) |
| Unstable or shock | 8(0.1%) | 10(0.2%) |
| Congestive heart failure | ||
| This admission | 382(5.9%) | 370(5.7%) |
| Before this admission | 123(1.9%) | 111(1.7%) |
| None | 6,006(92.2%) | 6,030(92.6%) |
| Malignant ventricular arrhythmia | 20(0.3%) | 19(0.3%) |
| Chronic obstructive pulmonary disease | 405(6.2%) | 409(6.3%) |
| Diabetes requiring medication | 1,922(29.5%) | 1,858(28.5%) |
| Renal failure | ||
| Requiring dialysis | 125(1.9%) | 119(1.8%) |
| Creatinine > 2.5 mg/dL (220 µmol/liter) | 51(0.8%) | 47(0.7%) |
| No renal failure | 6,335(97.3%) | 6,345(97.5%) |
| New York State PCI risk score for in- hospital mortality, mean (SD) |
3.4(2.7) | 3.3(2.8) |
| Type of stent | ||
| Bare-metal stents (BMS) only | 366(5.6%) | 366(5.6%) |
| Drug-eluting stents (DES) only | 5,687(87.3%) | 5,687(87.3%) |
| Both BMS and DES | 458(7.0%) | 458(7.0%) |
*
All p values > 0.10.